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ABSTRACT
Background and the purpose of the study: Many drug substances along with a variety of naturally 
occurring dietary or herbal components interact with the CYP enzyme system. The present 
study was aimed to investigate the effect of pomegranate juice pre-treatment on the transport of 
carbamazepine across the rat intestine
Methods: The transport of carbamazepine across different parts of rat intestine was studied 
by everted and non-everted sac methods. The control and pomegranate juice (10 ml Kg-1 for 
7 days) pre-treated rats were sacrificed and isolated the intestine. The sacs of intestine were 
prepared, treated with carbamazepine solution and then placed in dulbeccos buffer. Samples 
were collected periodically and the drug content was estimated using HPLC. 
Results and conclusion: The results show that there was a significant (p<0.05) difference in the 
transport of carbamazepine from the intestinal sacs of pretreated with pomegranate juice and 
control. It seems that pomegranate juice might have induced CYP3A4 enzymes and hence drug 
is extensively metabolized  
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INTRODUCTION
Drug substances along with dietary or herbal 
components may interact with CYP enzyme system 
and induce or inhibit one or more CYP iso-forms 
which result in increase or decrease of the plasma 
drug concentration. Plant products with a number 
of ingredients have diverse chemical nature and 
increase in their uses may raise the possibility for 
drug-drug and/or drug-food interactions which 
may alters drug bioavailability through its effect on 
absorption, distribution and elimination.     
The CYP3A families of enzymes constitute the most 
predominant phase I drug metabolizing enzymes 
estimated  to  metabolize  50-70%  of  currently 
administered drugs. CYP3A4 is the most abundant 
form (1, 2) present primarily in the hepatocytes and 
enterocytes (3). 
Pomegranate (Punica granatum) fruits are globally 
consumed in fresh, processed forms such as juice, 
jam, wine and oil and in extract supplements. They 
contain diverse range of phytochemicals including 
polyphenols like punicalagin (PA), ellagic acid (EA), 
gallotannins, anthocyanins and other flavonoids (4). 
PA is the most abundant of these polyphenols, and 
EA has shown anti-carcinogenic properties, through   
induction of cell cycle arrest as well as apoptosis and 
inhibition of tumor formation and growth in animals. 
Pomegranate juice consumption has shown potent 
antioxidant  activity,  resulting  in  beneficial  health 
effects such as inhibition of low density lipoprotein 
oxidation and decrease in cardiovascular diseases 
(5). High pomegranate consumption may increase 
the possibility of interaction with drugs. Hence it is 
important to assess this effect as there are few reports 
on CYP3A-mediated drugs interaction.
Carbamazepine is an anticonvulsant which is used in 
the treatment of partial seizures, tonic-clonic seizures 
and trigeminal neuralgia. Simultaneous consumption 
of grapefruit juice with a number of therapeutic 
agents that are subject to first pass intestinal/hepatic 
metabolism have resulted in higher plasma levels 
with subsequent adverse effects and inhibition of   
intestinal CYP3A4 (6, 7).  
The present study was aimed to investigate the 
effect of pomegranate juice pre-treatment on the 
transport of carbamazepine with involvement of 
CYP3A4.
MARERIAL AND METHODS
Materials
Carbamazepine and sodium butyrate were gifts from 
Dr. Reddy’s Lab Ltd.(Hyderabad, India), Dulbeccos 
phosphate buffer pH of 7.4 (Hi Media Ltd Mumbai, 255
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India), Methanol, Acetonitrile (E. Merck Ltd 
Mumbai, India) and all chemicals used in this study 
were of AR grade. 
Preparation of pomegranate juice
Pomegranate fruits were cut into pieces, removed 
the rind, separated the seeds, grounded in a mixer 
(Remi, Mumbai, India) and then filtered to get clear 
juice. The juice used in this study was collected from 
the pomegranate fruits of the same plant. 
Experimental animals
Male Wistar rats weighing about 200±25  g  were 
selected and the study was conducted according to 
the protocol approved by animal ethics committee, 
Kakatiya University, India.
Methods
In vitro transport study 
The transport of carbamazepine across rat intestine 
(duodenum, jejunum, ileum and colon) was studied 
by using in vitro everted (15) and non-everted sac 
methods (8). The rats were treated separately with 
pomegranate juice (10 ml.Kg-1) and sodium butyrate 
(0.5 mg.Kg-1) in groups of 3 for 7 days sacrificed, 
isolated the intestinal segments isolated and then the 
sacs were prepared. The drug solution was placed 
in sac and kept in dulbeccos buffer. Samples were 
collected at pre-set time points by replacing with 
fresh buffer and their drug contents were estimated 
using validated HPLC method. Control experiments 
were also performed. 
Precipitation method
Methanol (100 µl) was added to intestinal sac 
samples (200 µl) vortexed on cyclomixer for 2 
min,  centrifuged  at  2500  rpm  for  15  min  using 
Biofuge Fresco Centrifuge (Heraeus, Germany) and 
supernatant was separated. Twenty microlitres of the 
supernatant was taken into Hamilton syringe and 
injected into HPLC column. 
   
HPLC Analysis
Shimadzu HPLC system equipped with a LC-10AT 
pump and SPD 10 AT UV visible detector and RP 
C18 column (120 mm x 4.6 mm ID, particle size 5 
µ) was used for the analysis of samples. The mobile 
phase was a mixture of methanol and water (50:50). 
The flow rate was 1 ml.min-1and the detection was 
carried out at 270 nm. The calibration curve was 
plotted in the range of 3.125 to 50 µg.ml-1. A linear 
relationship was observed between the concentration 
and the peak area of carbamazepine with a correlation 
coefficient (r2 = 0.999).
 The required studies were carried out to estimate 
the precision and accuracy of the HPLC method of 
analysis of carbamazepine. The limit of detection 
was 0.25 µg.ml-1. The average recovery of the drug 
was 95.75%. The intra day R.S.D (%) was less than 
7. 29% and the inter day R.S.D (%) was less than       
7. 64% (n=5).
Statistical analyses
The in vitro results were compared by student t-test 
using Sigma Stat Software (Jandel Scientific Sigma 
stat  version  1,  1992-94). A  value  of  P<0.05  was 
considered to be statistically significant.
RESULTS AND DISCUSION 
In the present study, the amount of transport of 
carbamazepine from non-everted sac (mucosal to 
serosal surface) and everted sac (serosal to mucosal 
surface) were determined in different regions of the 
rat intestine of the control, pomegranate and sodium 
butyrate treated groups (Table1). Results of this 
study reveals that the transport of carbamazepine 
in non-everted and everted sac methods was 
reduced by the treatment of pomegranate juice, 
in comparison to the control and sodium butyrate 
treated groups.  
The percentage of the change in drug transported was 
high in all parts of intestine treated with pomegranate 
juice and very low in the case of sodium butyrate 
treated group.  
A growing number of studies have documented 
interaction of grape juice with drugs that are 
metabolized by the cytochrome P450 3A subfamily 
(CYP3A), in particular by the CYP3A4 and CYP3A5 
enzymes.
Carbamazepine is mainly metabolized by CYP3A4 
to active metabolite carbamazepine- 10, 11-epoxide. 
Some reports have shown that carbamazepine 
regulates intestinal p-glycoprotein and multi-drug 
resistance  protein  and  influences  disposition  of 
talinolol in humans (9).
On the basis of a linear relationship between in 
vitro everted sac and the in vivo studies (10) it has 
been suggested that in vivo P-gp related drug-drug 
interactions can be predicted by in vitro everted 
sac studies. These workers also suggested that 
drug-drug interactions related to P-gp mediated 
transport in human intestine could be predicted 
by in vivo (exsorption across rat ileum) or in vitro 
(everted rat intestine) transport study using rat 
ileum which are comparable with the transport 
studies in Caco-2 cell monolayers. The non-
everted sac model was originally used to evaluate 
drug transport mechanisms (11). Evered gut sac 
method also has been used to assess the role of 
P-glycoprotein on the intestinal secretion of the 
ivermectin (12). 
In the earlier studies it was reported that pomegranate 
juice influenced the intestinal transport of buspirone 
in rats (13). It have been reported that the 
component(s) of pomegranate inhibit the CYP3A-
mediated metabolism of carbamazepine (14) by a 
manner similar to that of grapefruit. 
Results of this in vitro study revealed that 256 Adukondalu et al / DARU 2010 18 (4) 254-259
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Figure 3. Cumulative transport pattern of carbamazepine in ileum everted sac in wister rats.
Figure 4. Cumulative transport pattern of carbamazepine in colon everted sac in Wistar rats.
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Fig 3. Cumulative transport pattern of carbamazepine in ileum everted sac in wister rats. 
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Fig 4. Cumulative transport pattern of carbamazepine in colon everted sac in Wistar rats. 
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Fig 3. Cumulative transport pattern of carbamazepine in ileum everted sac in wister rats. 
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carbamazepine transport across the small intestine is 
much affected by pomegranate juice pre-treatment. 
In this study, the Mean ± S.D. cumulative absorption 
and exsorption concentrations of carbamazepine 
decreased after pre-treatment with pomegranate 
juice. In sodium butyrate treated group significant 
difference was not observed in normal and everted 
sac studies. This observation indicated the role of 
CYP3A4 on carbamazepine metabolism. The study 
revealed that pre-treatment with pomegranate juice 
acts as CYP3A4 inducer. 
Part of
Intestine
Control group Pomegranate treated group Sodium.butyrate treated group
Non-everted (µg) Everted (µg) Non-everted (µg) Everted (µg) Non-everted (µg) Everted (µg)
Duodenum 12.4±0.14 13.1± 0.2 7.07± 1.0 12.29±0 .7 11.9± 1.0 † 15.5± 0.3
Jejunum 13.3±0.66 15.2± 0.2 8.96±0 .32 11.87± 0.3 13.4±0 .4† 14.3± 0.3
Ileum 9.97± 0.77 17.1± 0.3 7.97± 0.05 14.82 ±0.4 10.3± 0.8 16.8± 0.8†
Colon 9.57± 0.48 14.0± 0.2 6.85± 0.7 9.89± 0.1 9.7± 1.2† 14.5±0.3†
Note: † groups with no significant P value 
Table 1. Cumulative amount (µg) of carbamazepine (Mean±S.D) transported from different parts of albino wistar rat small intestine 
(n=3) after 120 min.
Part of intestine
Pomegranate treated Sodium butyrate treated
Non-everted (%) Everted (%) Non-everted (%) Everted (%)
Duodenum 42.9 6 4 18
Jejunum 31.6 22 2 5
Ileum 20 13 7 1.7
Colon 28.4 29.3 2 3.5
Table 2. The percentage of changes in cumulative amount of carbamazepine transport in pomegranate juice and sodium butyrate treated 
groups.
CONCLUTION
The pomegranate juice pre-treatment decreased 
intestinal permeation of carbamazepine which may 
be due to induction of CYP3A4 enzyme. Though 
there are reports on inhibition of carbamazepine 
metabolism by short pre-treatment with pomegranate 
juice (14), pre-treatment of rats for longer period 
(i.e, 7 days) decreased intestinal permeation of 
carbamazepine probably due to induction of 
CYP3A4 enzyme. Further studies are recommended 
to prove their effects in human beings or animals.
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